INVOLVEMENT OF THE RENIN-ANGIOTENSIN SYSTEM IN ISCHEMIC DAMAGE AND REPERFUSION ARRHYTHMIAS IN THE ISOLATED PERFUSED RAT-HEART

被引:52
作者
FLEETWOOD, G [1 ]
BOUTINET, S [1 ]
MEIER, M [1 ]
WOOD, JM [1 ]
机构
[1] CIBA GEIGY AG, DIV PHARMACEUT, CARDIOVASC RES DEPT, K-1251015, CH-4002 BASEL, SWITZERLAND
关键词
RENIN; ANGIOTENSIN; MYOCARDIUM; ISCHEMIA; ARRHYTHMIAS;
D O I
10.1097/00005344-199103000-00001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have investigated the contribution of the renin-angiotensin system to the damage caused by 40-min global ischemia in the isolated rat heart. A converting enzyme inhibitor, enalaprilat (70 nM), an angiotensin II receptor antagonist, compound 89 (2-mu-M), and an inhibitor of rat renin, CGP 44099A (20 nM), given before ischemia reduced the median duration of ventricular fibrillation on reperfusion to a similar extent (5.53, 5.72, and 5.14 min, respectively, compared to 13.98 min in the control group) but had no effect on creatine phosphokinase release (22.2 +/- 2.6, 22.1 +/- 6.8, and 24.1 +/- 3.6, IU/30 min, respectively, compared to 19.9 +/- 1.9 IU/30 min) or recovery of left ventricular developed pressure (67 +/- 6, 73 +/- 7 and 71 +/- 6%, respectively, compared to 66 +/- 3% after 30 min reperfusion). The increase in coronary resistance and left ventricular diastolic pressure on reperfusion was not affected by any of the agents. All three agents also tended to reduce the duration of ventricular fibrillation when given only on reperfusion. We conclude that angiotensinogen is present in the rat heart and it is converted to angiotensin I by a renin or a renin-like aspartic proteinase. The angiotensin I is converted to angiotensin II by converting enzyme. The angiotensin II formed is an important mediator of postreperfusion ventricular fibrillation in the isolated rat heart but does not contribute to the reduction in mechanical function produced by global ischemia in this preparation.
引用
收藏
页码:351 / 356
页数:6
相关论文
共 21 条
[1]  
BRAUNWALD E, 1981, ACTA MED SCAND, P123
[2]   ANGIOTENSINOGEN GENE IS EXPRESSED AND DIFFERENTIALLY REGULATED IN MULTIPLE TISSUES OF THE RAT [J].
CAMPBELL, DJ ;
HABENER, JF .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (01) :31-39
[3]  
CHIU AT, 1990, J PHARMACOL EXP THER, V252, P711
[4]   CAPTOPRIL - A FREE-RADICAL SCAVENGER [J].
CHOPRA, M ;
SCOTT, N ;
MCMURRAY, J ;
MCLAY, J ;
BRIDGES, A ;
SMITH, WE ;
BELCH, JJF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (03) :396-399
[5]   CONCENTRATION-DEPENDENT PROTECTION BY CAPTOPRIL AGAINST MYOCARDIAL DAMAGE DURING ISCHEMIA AND REPERFUSION IN A CLOSED CHEST PIG MODEL [J].
DEGRAEFF, PA ;
VANGILST, WH ;
BEL, K ;
DELANGEN, CDJ ;
KINGMA, JH ;
WESSELING, H .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 9 :S37-S42
[6]   EFFECT OF VASODILATOR DRUGS ON CORONARY-OCCLUSION AND REPERFUSION ARRHYTHMIAS IN ANESTHETIZED DOGS [J].
ELFELLAH, MS ;
OGILVIE, RI .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 (05) :826-832
[7]   ANGIOTENSIN-I CONVERTING ENZYME [J].
ERDOS, EG .
CIRCULATION RESEARCH, 1975, 36 (02) :247-255
[8]   LIMITATION OF EXPERIMENTAL INFARCT SIZE BY AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR [J].
ERTL, G ;
KLONER, RA ;
ALEXANDER, RW ;
BRAUNWALD, E .
CIRCULATION, 1982, 65 (01) :40-48
[9]   PRESERVATION OF ISCHEMIC MYOCARDIUM BY A NEW CONVERTING ENZYME-INHIBITOR, ENALAPRILIC ACID, IN ACUTE MYOCARDIAL-INFARCTION [J].
HOCK, CE ;
RIBEIRO, LGT ;
LEFER, AM .
AMERICAN HEART JOURNAL, 1985, 109 (02) :222-228
[10]  
Langendorff O., 1895, PFLUEGERS ARCH, V61, P291, DOI [DOI 10.1007/BF01812150, 10.1007/BF01812150]